Physician profile
John J Kokemor
NPI 1013917517
$495.68
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $496.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $112.04 | 2019 | |
| Glaxosmithkline, LLC. | $77.84 | 2019 | |
| Janssen Pharmaceuticals, INC | $45.27 | 2019 | |
| Astellas Pharma US INC | $44.15 | 2019 | |
| Amarin Pharma, INC. | $37.60 | 2019 | |
| Sanofi-Aventis U.S. LLC | $29.24 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $18.67 | 2019 | |
| Daiichi Sankyo INC. | $15.53 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $14.46 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $13.75 | 2019 | |
| Vifor Pharma, INC. | $13.57 | 2019 | |
| Merck Sharp & Dohme LLC | $13.50 | 2019 | |
| Shire North American Group INC | $12.95 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $12.50 | 2019 | |
| Lilly USA, LLC | $11.98 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $11.75 | 2019 | |
| Pfizer INC. | $10.88 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Kokemor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.